Germany has traditionally been seen as a country with strong healthcare coverage. But when it comes to fertility treatment, the reality is far more complex and increasingly, insufficient for modern family-building needs.
A new movement of employer-sponsored fertility insurance is now entering the German market, signalling a shift that has already taken hold in the United States. To understand why this matters, it’s worth looking at the gap between what the system provides today, and what people actually need.
The German system and shortcomings of the coverage that exist
Fertility treatment in Germany is not entirely uncovered. Statutory health insurance (GKV) typically reimburses around 50% of the costs for treatments like IVF or ICSI. However, this support comes with strict conditions:
• Only married heterosexual couples are eligible
• Both partners must meet age requirements
• A medical diagnosis of infertility is required
• Coverage is limited to a small number of treatment cycles
Even for those who qualify, the financial burden can still be substantial. A single IVF cycle can cost several thousand euros, meaning couples often face significant out-of-pocket expenses.
For many others, the system simply does not apply at all:
• Single individuals
• Same-sex couples
• People pursuing fertility preservation (e.g., egg freezing) or egg donation
Private insurance can sometimes offer broader coverage, but it is typically tied to individual contracts, medical necessity, and underwriting making access uneven and unpredictable.
The result: Germany has coverage, but not inclusivity, flexibility, or completeness.
Why the need for fertility insurance is growing now
Several societal and workplace trends are putting pressure on this outdated model:
1. Changing family structures
The current system has not kept pace with realities as families today don’t fit into one single standard, as more people are:
• Delaying parenthood starting families later in life
• Pursuing parenthood outside traditional marriage and new family formations’
2. Rising fertility challenges
Infertility is increasing globally, and Germany is no exception. At the same time, awareness and willingness to seek treatment is growing.
3. Talent competition and employee expectations
Employers are under increasing pressure to offer benefits that reflect real-life needs. Fertility support is becoming a differentiator, especially for:
• Knowledge workers
• International talent
• Younger employees planning families later
A new model arrives with employer-sponsored fertility insurance
Into this gap steps a new type of solution: employer-paid fertility insurance. Recently, Swedish insurer Eir Försäkring, in partnership with healthtech company Onuava, launched a fertility insurance product specifically targeting the German market. While fertility benefits are well established in the U.S., this marks one of the first structured attempts to bring a similar model to Germany.
EIR Försäkring and Onuava launch Fertility+ – Europe’s first corporate health insurance solution for fertility and family building — Eir Försäkring
Unlike traditional coverage, this model:
– Is paid by the employer, not dependent on personal insurance status
– Offers fixed financial support for treatments like IVF, insemination, and egg freezing
– Includes support services, such as medical guidance and mental health resources
– Is inclusive by design, regardless of marital status, gender, or sexual orientation
– Typically avoids waiting periods and strict underwriting
In short, it shifts fertility support from a conditional medical reimbursement to a proactive employee benefit.
Why this model has worked in the U.S.
In the United States, fertility benefits have become increasingly common among large employers and tech companies. The reasons are clear:
– Fertility support is seen as a high-impact, high-value benefit
– It improves employee retention and satisfaction
– It supports diversity and inclusion goals
– It aligns with broader trends in personalized healthcare benefits
Companies like Google, Meta, and others have normalized fertility coverage as part of competitive benefits packages.
Concluding remarks – fertility treatments in Germany at an inflection point?
The combination of:
• Limited public coverage
• Changing demographics
• Increasing employer competition
…creates the perfect conditions for employer-sponsored fertility insurance to take hold.
If adoption follows patterns seen in the U.S., we can expect:
• Early uptake among large and international companies
• Gradual expansion to mid-sized employers
• Increased pressure on traditional insurers to adapt
• A broader redefinition of what “health benefits” include
Fertility care in Germany has long existed in a narrow, regulated framework. But the needs of individuals and the expectations placed on employers have evolved far beyond that model.
Employer-sponsored fertility insurance doesn’t replace the existing system. Instead, it fills its most critical gaps: access, inclusivity, and predictability.
What’s emerging is not just a new insurance product, but a shift in how fertility is understood, moving from a private burden to a shared responsibility between individuals, employers, and the broader healthcare ecosystem. And if the U.S. is any indication, this shift is only just beginning.
April 30, 2026